Suchergebnisse - "Fibrinolytic Agents"

PubPharm (232)

1

Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke : A Phase 2 Randomized Controlled Trial

enthalten in: Stroke | 2024

von Li, S. | Wang, X. | Jin, A. | +14

2

Safety of Bivalirudin Combined with Ticagrelor in the Emergency PCI in Patients with Acute ST-Segment Elevation Myocardial Infarction

enthalten in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis | 2022

von Wang, Z. | Chen, Y. | Liu, M. | +5

3

Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA) : a randomised, open label, multicentre, parallel-group, non-inferiority trial

enthalten in: The Lancet. Neurology | 2021

von Gusev, E. | Martynov, M. | Nikonov, A. | +52

CommentIn: Lancet Neurol. 2021 Sep;20(9):687-689. - PMID 34418384

4

Safety and efficacy study of prourokinase injection during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction

enthalten in: Coronary artery disease | 2021

von Jiang, W. | Xiong, X. | Du, X. | +3

5

Twelve-month mortality from the "How Effective are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention (HEAT-PPCI) Trial"

enthalten in: International journal of cardiology | 2020

von Blake, S. | Shahzad, A. | Kemp, I. | +3

6

Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients : a randomized, controlled study

enthalten in: BMC cardiovascular disorders | 2020

von Wu, Y. | Fu, X. | Feng, Q. | +4

7

Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema : A Randomized Clinical Trial

enthalten in: JAMA pediatrics | 2020

von Livingston, M. | Mahant, S. | Connolly, B. | +19

CommentIn: JAMA Pediatr. 2020 Apr 1;174(4):323-324. - PMID 32011656

8

Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE) : 5-year follow up of a phase 3 study

enthalten in: The Lancet. Haematology | 2020

von Kiladjian, J. | Zachee, P. | Hino, M. | +19

9

The protein C activator AB002 rapidly interrupts thrombus development in baboons

enthalten in: Blood | 2020

von Tucker, E. | Verbout, N. | Markway, B. | +9

10

Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection : evidence from the MIST2 randomised controlled trial

enthalten in: The European respiratory journal | 2019

von Luengo-Fernandez, R. | Penz, E. | Dobson, M. | +4

CommentIn: Eur Respir J. 2019 Aug 1;54(2):. - PMID 31371440

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]